Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,701 to 1,720 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma. | Front Endocrinol (Lausanne) | 2022 | 36299451 | PubTator, text mining | PubMed |
| Innate Immunity, Inflammation, and Intervention in HBV Infection. | Viruses | 2022 | 36298831 | PubTator, text mining | PubMed |
| Reduction of Methyltransferase-like 3-Mediated RNA N6-Methyladenosine Exacerbates the Development of Psoriasis Vulgaris in Imiquimod-Induced Psoriasis-like Mouse Model. | Int J Mol Sci | 2022 | 36293529 | PubTator, text mining | PubMed |
| A Mitophagy-Related Gene Signature for Subtype Identification and Prognosis Prediction of Hepatocellular Carcinoma. | Int J Mol Sci | 2022 | 36292980 | PubTator, text mining | PubMed |
| The METTL3 RNA Methyltransferase Regulates Transcriptional Networks in Prostate Cancer. | Cancers (Basel) | 2022 | 36291932 | PubTator, text mining | PubMed |
| The Role of m6A Modification and m6A Regulators in Esophageal Cancer. | Cancers (Basel) | 2022 | 36291923 | PubTator, text mining | PubMed |
| m6A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA. | Cancers (Basel) | 2022 | 36291811 | PubTator, text mining | PubMed |
| The Role of N6-Methyladenosine Modification in Microvascular Dysfunction. | Cells | 2022 | 36291060 | PubTator, text mining | PubMed |
| M6A RNA Methylation Mediates NOD1/NF-kB Signaling Activation in the Liver of Piglets Challenged with Lipopolysaccharide. | Antioxidants (Basel) | 2022 | 36290677 | PubTator, text mining | PubMed |
| Effects of Moderate-Intensity Continuous Training and High-Intensity Interval Training on Testicular Oxidative Stress, Apoptosis and m6A Methylation in Obese Male Mice. | Antioxidants (Basel) | 2022 | 36290597 | PubTator, text mining | PubMed |
| Interplay between the m6A Epitranscriptome and Tumor Metabolism: Mechanisms and Therapeutic Implications. | Biomedicines | 2022 | 36289851 | PubTator, text mining | PubMed |
| METTL3 acetylation impedes cancer metastasis via fine-tuning its nuclear and cytosolic functions. | Nat Commun | 2022 | 36289222 | PubTator, text mining | PubMed |
| The feedback loop of METTL14 and USP38 regulates cell migration, invasion and EMT as well as metastasis in bladder cancer. | PLoS Genet | 2022 | 36288387 | PubTator, text mining | PubMed |
| IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma. | Biosci Rep | 2022 | 36281789 | PubTator, text mining | PubMed |
| WTAP mediates the anti-inflammatory effect of Astragalus mongholicus polysaccharide on THP-1 macrophages. | Front Pharmacol | 2022 | 36278233 | PubTator, text mining | PubMed |
| lncRNAs AC156455.1 and AC104532.2 as Biomarkers for Diagnosis and Prognosis in Colorectal Cancer. | Dis Markers | 2022 | 36277972 | PubTator, text mining | PubMed |
| Application of mesenchymal stem cell-derived exosomes from different sources in intervertebral disc degeneration. | Front Bioeng Biotechnol | 2022 | 36277386 | PubTator, text mining | PubMed |
| Investigation of the biomarkers involved in ectopic ossification: The shared mechanism in ossification of the spinal ligament. | Front Genet | 2022 | 36276940 | PubTator, text mining | PubMed |
| TRAT1 overexpression delays cancer progression and is associated with immune infiltration in lung adenocarcinoma. | Front Oncol | 2022 | 36276113 | PubTator, text mining | PubMed |
| Identification of bromodomain-containing proteins prognostic value and expression significance based on a genomic landscape analysis of ovarian serous cystadenocarcinoma. | Front Oncol | 2022 | 36276071 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=86